Back to Journals » International Journal of Nanomedicine » Volume 8 » Issue 1

Combinatorial evaluation of in vivo distribution of polyanhydride particle-based platforms for vaccine delivery

Authors Petersen LK, Huntimer L, Walz K, Ramer-Tait A, Wannemuehler MJ, Narasimhan B

Received 16 March 2013

Accepted for publication 23 April 2013

Published 18 June 2013 Volume 2013:8(1) Pages 2213—2225


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Latrisha K Petersen,1 Lucas Huntimer,2 Katharine Walz,1 Amanda Ramer-Tait,2 Michael J Wannemuehler,2 Balaji Narasimhan1

1Department of Chemical and Biological Engineering, Iowa State University, Ames, IA, USA; 2Department of Veterinary Microbiology and Preventive Medicine, Iowa State University, Ames, IA, USA

Abstract: Several challenges are associated with current vaccine strategies, including repeated immunizations, poor patient compliance, and limited approved routes for delivery, which may hinder induction of protective immunity. Thus, there is a need for new vaccine adjuvants capable of multi-route administration and prolonged antigen release at the site of administration by providing a depot within tissue. In this work, we designed a combinatorial platform to investigate the in vivo distribution, depot effect, and localized persistence of polyanhydride nanoparticles as a function of nanoparticle chemistry and administration route. Our observations indicated that the route of administration differentially affected tissue residence times. All nanoparticles rapidly dispersed when delivered intranasally but provided a depot when administered parenterally. When amphiphilic and hydrophobic nanoparticles were administered intranasally, they persisted within lung tissue. These results provide insights into the chemistry- and route-dependent distribution and tissue-specific association of polyanhydride nanoparticle-based vaccine adjuvants.

Keywords: combinatorial, polyanhydride, nanoparticle, live animal imaging, distribution

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]